Exploring the Potential of CRISPR-Cas9 Gene Editing for Sickle Cell Disease and Malaria Resistance: A Systematic Review
Current evidence supports separate translational pathways in SCD and malaria applications remaining predominantly preclinical, with clinical progress established in SCD and malaria applications remaining predominantly preclinical.
Comfort Ohunene Matthew, B. Inyang, Verity Ghansah et al.
· Epidemiology and Health Data... · 0 citations